- Home
- SDGR
SDGR
Schrodinger Inc.
as 07-26-2024 4:00pm EST
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
Upcoming Earnings Alert:
Get ready for potential market movements as Schrodinger Inc. SDGR prepares to release earnings report on 31 Jul 2024.
| Founded: | 1990 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 1.6B | IPO Year: | 2020 |
| Target Price: | $38.90 | AVG Volume (30 days): | 650.3K |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.97 | EPS Growth: | N/A |
| 52 Week Low/High: | $18.21 - $52.81 | Next Earning Date: | 07-31-2024 |
| Revenue: | $188,482,000 | Revenue Growth: | -4.36% |
| Revenue Growth (this year): | -3.51% | Revenue Growth (next year): | 35.85% |
Stock Insider Trading Activity of Schrodinger Inc. (SDGR)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Porges Geoffrey Craig | SDGR | EVP & CFO | Mar 4 '24 | Sell | $26.35 | 3,315 | $87,360.20 | 5,685 | SEC Form 4 |
| Herman Jenny | SDGR | SVP & Controller | Feb 12 '24 | Sell | $28.29 | 787 | $22,264.23 | 11,761 | SEC Form 4 |
| Abel Robert Lorne | SDGR | See Remarks | Feb 12 '24 | Sell | $27.55 | 1,205 | $33,197.75 | 9,340 | SEC Form 4 |
| Tran Yvonne | SDGR | EVP, CLO & CPO | Feb 12 '24 | Sell | $28.29 | 758 | $21,443.82 | 11,963 | SEC Form 4 |
| Lorton Kenneth Patrick | SDGR | EVP, CTO & COO, Software | Feb 12 '24 | Sell | $28.29 | 901 | $25,489.29 | 36,487 | SEC Form 4 |
Latest Schrodinger Inc. News
SDGR Breaking Stock News: Dive into SDGR Ticker-Specific Updates for Smart Investing
Business Wire
14 hours ago
Schrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive Toxicology
Zacks
a day ago
Omnicell (OMCL) Expected to Beat Earnings Estimates: Should You Buy?
Zacks
2 days ago
Earnings Preview: Schrodinger, Inc. (SDGR) Q2 Earnings Expected to Decline
Argus Research
3 days ago
SDGR: Lowering target price to $18.00
Simply Wall St.
3 days ago
We're Not Very Worried About Schrödinger's (NASDAQ:SDGR) Cash Burn Rate
Business Wire
9 days ago
Schrödinger to Announce Second Quarter 2024 Financial Results on July 31
Argus Research
10 days ago
SDGR: Raising target price to $19.00
Business Wire
11 days ago
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Compare SDGR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SDGR Schrodinger Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.